Cargando…
New Targeted Therapies for Thyroid Cancer
The increasing incidence of thyroid cancer is associated with a higher number of advanced disease characterized by the loss of cancer differentiation and metastatic spread. The knowledge of the molecular pathways involved in the pathogenesis of thyroid cancer has made possible the development of new...
Autores principales: | Antonelli, Alessandro, Fallahi, Poupak, Ferrari, Silvia M, Ruffilli, Ilaria, Santini, Francesca, Minuto, Michele, Galleri, David, Miccoli, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271315/ https://www.ncbi.nlm.nih.gov/pubmed/22654562 http://dx.doi.org/10.2174/138920211798120808 |
Ejemplares similares
-
New Targeted Molecular Therapies for Dedifferentiated Thyroid Cancer
por: Antonelli, Alessandro, et al.
Publicado: (2010) -
New Therapies for Dedifferentiated Papillary Thyroid Cancer
por: Fallahi, Poupak, et al.
Publicado: (2015) -
MON-565 Patients Thyroidectomized For Thyroid Cancer (without Malabsorption) In Treatment With Oral Liquid L-thyroxine (L-T4) Formulation
por: Fallahi, Poupak, et al.
Publicado: (2019) -
Oral L‐thyroxine liquid versus tablet in patients submitted to total thyroidectomy for thyroid cancer (without malabsorption): A prospective study
por: Fallahi, Poupak, et al.
Publicado: (2018) -
MON-566 Early Diagnosis of Lymph Node Metastases by Serum Tg and Neck Ultrasonography, and Long Term Follow Up After Radioiodine and/or Surgical Treatment in Patients with Papillary or Follicular Thyroid Cancer.
por: Fallahi, Poupak, et al.
Publicado: (2019)